BeiGene, Ltd. (BGNE)
BeiGene, Ltd. (BGNE)
$135.52 USD
Updated Sep 20 12:00am
Add BGNE to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 216 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
BGNE Stock Chart More Charts
BGNE Price/Volume Stats
| Current price | $135.52 |
| Prev. close | $132.95 |
| Day low | $132.03 |
| Day high | $137.86 |
| 50-day MA | $134.29 |
| 200-day MA | $131.93 |
| 52-week high | $179.57 |
| 52-week low | $105.19 |
| Volume | 423,500 |
| Avg. volume | 320,020 |
| Dividend yield | N/A |
| Market Cap | 6.43B |
BeiGene, Ltd. (BGNE) Company Bio
BeiGene, Ltd., a clinical-stage biopharmaceutical company, discovers and develops various oncology drugs in the People’s Republic of China. The company was founded in 2010 and is based in the Cayman Islands.
Top Stories View All
Why this analyst just rated shares of HEXO a “buy”
What is the Worst Case Scenario for Stocks?
Best & Worst Performing Stock Industries for September 20, 2019
Best & Worst Performing Small Cap Stocks for September 20, 2019
Best & Worst Performing Mid Cap Stocks for September 20, 2019
View All Top Stories
Loading social stream, please wait...